Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

IL-18 signaling helps mature Tregs move into the thymus.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

IL-18 signaling helps mature Tregs move into the thymus.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Developing human skin has immune cells with memory-like features.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Clonally expanded CD8+ T cells cause alopecia areata.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Dual TCR Treg cells are common in mouse tissues and vary by location.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Human thymus has stem cells that can self-renew and maintain their identity.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Gamma/delta T cells help defend skin against heavy metals.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.